Dr. Yu Xie 谢宇
Chief Physician
Department of Urology, Hunan Cancer Hospital, Changsha
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of urinary tract tumors, including kidney, bladder, prostate, renal pelvis, ureter, testicular, and adrenal cancers. Specializes in minimally invasive therapy and Da Vinci robotic surgery.
Dr. Xie is a Chief Physician, Department Director, and doctoral supervisor at Hunan Cancer Hospital. A senior visiting scholar at MD Anderson Cancer Center, Dr. Xie leads the Hunan Kidney Tumor Clinical Medical Research Center. The doctor performed Hunan's first fourth-generation Da Vinci robotic surgery and pioneered 3D printing-assisted nephron-sparing minimally invasive surgery for kidney tumors in China.
Professional roles
- Vice Chair, Prostate Tumor Integrated Rehabilitation Committee, China Anti-Cancer Association
- Standing Committee Member, Tumor Plastic and Functional Surgery Branch, International Exchange and Promotion Association for Medical and Health Care
- Member, Kidney Cancer Professional Committee, Chinese Society of Clinical Oncology (CSCO)
- Chair, Integrated Oncology Professional Committee, Hunan Anti-Cancer Association
Name order: in Chinese the family name comes first (Xie Yu). Papers usually list the name as Yu Xie or Xie Y.
Selected publications
36 papers on PubMed matched by name and affiliation; 18 as first or senior author since 2016. Most recent first- or senior-author papers:
- Biochem Biophys Res Commun, 2026 (senior author): Identification of molecular subtypes in clear cell renal cell carcinoma based on chromatin regulators and tumor immune microenvironment profiling. PubMed 42600326
- Cancer Biother Radiopharm, 2026 (senior author): Precision Selection for Targeted Radionuclide Therapy in Prostate Cancer: Biparametric MRI Radiomics Combined with Serum Bone Turnover Biomarkers for Predicting Postoperative Bone Metastasis. PubMed 42750630
- Inflamm Res, 2026 (senior author): The characterization of RUNX1-mediated macrophage polarization requires a multidimensional perspective beyond the M1/M2 binary. PubMed 41843115
- Aging Clin Exp Res, 2026 (senior author): Bridging the gap between microbiome function and clinical benefit in sarcopenia. PubMed 41680567
- Aging Dis, 2026 (senior author): Expanding on Gut Microbiota Insights in Sarcopenia and Osteoporosis. PubMed 41525178
- J Nanobiotechnology, 2025 (senior author): Enzyme-driven triplex structure-based DNA logic circuits. PubMed 41444625
- Sci Rep, 2025 (senior author): Small cell size circulating tumor cells predict the prognosis of high-risk non-muscle invasive bladder cancer patients. PubMed 41266607
- Cancer Med, 2025 (senior author): MMRN1 Facilitates Renal Cell Carcinoma by Activating AMPK/MMPs Axis. PubMed 40583724
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion